The role of government and private insurers in guiding and implementing pharmacoeconomic analyses.
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 13 (4) , 383-387
- https://doi.org/10.2165/00019053-199813040-00001
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Cost-Effectiveness AnalysesNew England Journal of Medicine, 1995
- Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and PotentialInternational Journal of Technology Assessment in Health Care, 1993
- Cost-Effectiveness and Cost-Benefit Analyses in the Medical LiteratureAnnals of Internal Medicine, 1992
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991